Literature DB >> 16840011

Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.

H Carrstensen1, R H Müller, B W Müller.   

Abstract

Fat emulsions for parenteral nutrition, stabilized by egg lecithin, were characterized in terms of parameters relevant to uptake by the reticuloendothelial system (RES), e.g. size distribution, surface hydrophobicity and adsorption of serum components as a measure of the degree of opsonization. Adsorption of serum components was quantified by zeta potential measurement. Fat emulsions for nutrition were compared with emulsions used for drug delivery and model drug carries for intravenous injection. The emulsions for drug delivery were stabilized by the blockcopolymers Poloxamer 188 and 407 (Pluronic F68 and F127) and Poloxamine 908. Model drug carriers were hydrophobic and hydrophilic polystyrene latex particles. Hydrophilic particles were prepared by adsorption of Poloxamine 908 (coating) onto the particle surface. The hydrophobicity and serum protein adsorption decreased from hydrophobic latex particles to egg lecithin emulsions and blockcopolymer emulsions and particles. The data correlated with that in the literature concerning liver uptake in vivo showing complete RES clearance of hydrophobic latex particles, reduced uptake of egg lecithin emulsions and avoidance of RES uptake by Poloxamine 908 coated particles.

Entities:  

Year:  1992        PMID: 16840011     DOI: 10.1016/0261-5614(92)90006-c

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  16 in total

Review 1.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 2.  Targeted Nanotherapies for the Treatment of Surgical Diseases.

Authors:  Courtney E Morgan; Molly A Wasserman; Melina R Kibbe
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

Review 3.  Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations.

Authors:  Yu Luo; Yanlong Hong; Lan Shen; Fei Wu; Xiao Lin
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

4.  The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes.

Authors:  Paul H Kierstead; Hideaki Okochi; Vincent J Venditto; Tracy C Chuong; Saul Kivimae; Jean M J Fréchet; Francis C Szoka
Journal:  J Control Release       Date:  2015-06-18       Impact factor: 9.776

5.  Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery.

Authors:  Zohreh Amoozgar; Joonyoung Park; Qingnuo Lin; Yoon Yeo
Journal:  Mol Pharm       Date:  2012-04-20       Impact factor: 4.939

Review 6.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

7.  Enhancing therapeutic efficacy through designed aggregation of nanoparticles.

Authors:  Tanmoy Sadhukha; Timothy S Wiedmann; Jayanth Panyam
Journal:  Biomaterials       Date:  2014-06-16       Impact factor: 12.479

Review 8.  Advanced materials and processing for drug delivery: the past and the future.

Authors:  Ying Zhang; Hon Fai Chan; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

9.  Nanodiamond as a Cytokine Sponge in Infectious Diseases.

Authors:  Wonbeak Yoo; Wonhwa Lee; Hong Nam Kim; Jiyoung Jeong; Hee Ho Park; June Hong Ahn; Dana Jung; Juheon Lee; Ji-Su Kim; Seung Whan Lee; Wan-Seob Cho; Seokho Kim
Journal:  Front Bioeng Biotechnol       Date:  2022-04-04

10.  Stealth properties to improve therapeutic efficacy of drug nanocarriers.

Authors:  Stefano Salmaso; Paolo Caliceti
Journal:  J Drug Deliv       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.